Healio: Driver training software program associated with fewer distractions in ADHD youth
Healio highlighted a recent trial published by University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers that found a driver training software program reduced how often adolescent drivers with ADHD took long glances away from the roadway.
Led by Jeffery N. Epstein, PhD, professor in UC's Department of Pediatrics in the College of Medicine, director of the Cincinnati Children's Center for ADHD and a pediatric psychologist, the research was published in the New England Journal of Medicine.
Teenage drivers with ADHD are twice as likely than neurotypical teens to be in an accident, the researchers wrote, noting a struggle for these teens to sustain visual attention while driving.
In the trial, the researchers evaluated the effectiveness of an enhanced version of the Focused Concentration and Attention Learning (FOCAL+) program, a desktop-based software program that features multiple sessions and simulator training "with immediate auditory feedback" designed to reduce long glances away from the road of 2 seconds or longer.
The teen drivers with ADHD randomly assigned to the FOCAL+ program were found to have significantly fewer long glances from the roadway.
Featured photo at top courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.